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Abstract
We developed an expression profiling array to examine pro-apoptotic and pro-survival genes in dog retinal
degeneration models. Gene-specific canine TaqMan assays were developed and included in a custom
real-time quantitative reverse transcription-PCR (qRT-PCR) array. Of the 96 selected genes, 93 belonged to
known relevant pro-apoptotic and pro-survival pathways, and/or were positive controls expressed in
retina, while three were housekeeping genes. Ingenuity Pathway Analysis (IPA) showed that the selected
genes belonged to expected biological functions (cell death, cell-mediated immune response, cellular
development, function, and maintenance) and pathways (death receptor signaling, apoptosis, TNFR1
signaling, and induction of apoptosis by HIV1). Validation of the profiling array was performed with RNA
extracted from cultured MDCK cells in the presence or absence of treatment with 10 μM staurosporin for
5 or 10 h. The vast majority of the genes showed positive amplifications, and a number of them also had
fold change (FC) differences > ±3 between control and staurosporin-treated cells. To conclude, we
established a profiling array that will be used to identify differentially expressed genes associated with
photoreceptor death or survival in canine models of retinal degenerative diseases with mutations in
genes that cause human inherited blindness with comparable phenotypes.
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Development and Validation of a Canine-Specific Profiling Array
to Examine Expression of Pro-Apoptotic and Pro-Survival Genes
in Retinal Degenerative Diseases
Sem Genini1, William A. Beltran1, and Gustavo D. Aguirre1
1Section of Ophthalmology, Department of Clinical Studies, School of Veterinary Medicine,
University of Pennsylvania, Philadelphia, PA 19104, USA

Abstract
We developed an expression profiling array to examine pro-apoptotic and pro-survival genes in
dog retinal degeneration models. Gene specific canine TaqMan assays were developed and
included in a custom real-time quantitative reverse transcription-PCR (qRT-PCR) array. Of the 96
selected genes, 93 belonged to known relevant pro-apoptotic and pro-survival pathways, and/or
were positive controls expressed in retina, while 3 were housekeeping genes. Ingenuity Pathway
Analysis (IPA) showed that the selected genes belonged to expected biological functions (cell
death, cell-mediated immune response, cellular development, function, and maintenance) and
pathways (death receptor signaling, apoptosis, TNFR1 signaling, and induction of apoptosis by
HIV1). Validation of the profiling array was performed with RNA extracted from cultured MDCK
cells in the presence or absence of treatment with 10 μM staurosporin for 5 or 10 hrs. The vast
majority of the genes showed positive amplifications, and a number of them also had fold change
(FC) differences > +/−3 between control and staurosporin-treated cells. To conclude, we
established a profiling array that will be used to identify differentially expressed genes associated
with photoreceptor death or survival in canine models of retinal degenerative diseases with
mutations in genes that cause human inherited blindness with comparable phenotypes.

46.1 Introduction
Photoreceptors, like other specialized cells, have the innate ability to die through varied
molecular mechanisms, and in response to multiple insults, whether genetic or acquired
(Melino et al. 2005). Since the description of apoptosis as one of the final pathways in
photoreceptor cell death (Chang et al. 1993; Portera-Cailliau et al. 1994), many studies have
examined different molecules and mechanisms involved in the process.
Multiple pathways have been reported to be relevant for both retinal cell death (Cottet and
Schorderet 2009; Doonan et al. 2005; Kunchithapautham and Rohrer 2007; Lohr et al. 2006;
Rohrer et al. 2004; Sancho-Pelluz et al. 2008; Werdehausen et al. 2007) and survival
(Barnstable and Tombran-Tink 2006; Bazan 2006; Jomary et al. 2006; Ueki et al. 2009;
Wenzel et al. 2005). These are dependent on the underlying mutation, the model, whether
naturally occurring or induced, the speed of the degenerative process, the cell class involved,
and other factors. Despite the abundance of such studies, the signaling pathways and
molecular mechanisms that link the mutations to the observed phenotypes are still unknown
for many of the photoreceptor degenerative diseases. One of these diseases is canine X-
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linked progressive retinal atrophy 2 (XLPRA2), caused by a 2-bp deletion in exon ORF15 of
the RPGR gene (Zhang et al. 2002). In two recent studies from our group, we characterized
by TUNEL labeling the time course of cell death in affected dogs (Beltran et al. 2006), and
identified by microarray analysis a number of non-classical apoptosis and mitochondriarelated genes that seemed to be involved in the degenerative process (Genini et al. 2010).
However, limitations of the latter study included the use of a custom canine cDNA array
with a limited number of genes, and without relevant pro- and anti-apoptotic genes.
Although for humans and rodent models a comprehensive suite of commercially-available
products can be used to analyze RNA and protein expressions of a large panel of genes
associated with biological pathways or specific disease states, these tools do not work or are
currently not available for the dog.
The aim of this study was to fill this gap by developing and validating a canine specific realtime quantitative reverse transcription-PCR (qRT-PCR) profiling array containing key genes
that are directly or indirectly involved in pro-apoptotic and pro-survival processes,
autophagy, and/or are related to microglia/macrophages, cells that have been recently
associated with retinal disease processes (Langmann 2007; Sasahara et al. 2008).

46.2 Materials and Methods
46.2.1 Development of the Canine-Specific qRT-PCR Array
The canine-specific custom-designed qRT-PCR profiling array (Table 46.1) was developed
in conjunction with Applied Biosystems (ABI, Foster City, CA). Canine specific sequences
of selected genes, identified from studies in other species, were submitted to ABI to develop
gene specific TaqMan assays (http://www3.appliedbiosystems.com/AB_Home/index.htm).
These contained unlabeled forward and reverse primers and FAM dye labeled TaqMan
MGB probes. The Ingenuity Pathway Analysis (IPA, Ingenuity System Inc., Redwood City,
CA) database was interrogated with the 96 genes on the array to better characterize
biological functions and pathways involved.
46.2.2 Validation of the qRT-PCR Array Using Madin-Darby Canine Kidney (MDCK) Cells
46.2.2.1 Cell Culture—MDCK cells were grown to 80% confluency in 60-mm Petri
dishes in Dulbecco’s modified Eagle’s medium (DMEM, with low glucose and L-glutamine,
without sodium bicarbonate) supplemented with 10% fetal bovine serum (FBS), 1%
penicillin and streptomycin, 1% sodium pyruvate, and 1% MEM non-essential amino acids
(Sigma-Aldrich, St. Louis, MO). At 5 and 10 hrs prior cell collection, control cells received
fresh supplemented DMEM medium, while treated cells received fresh supplemented
DMEM medium containing 10 μM staurosporin (Sigma-Aldrich). For each time point (5 or
10 hrs) and cell type (control or staurosporin-treated), the experiment was done in duplicate,
one Petri dish was used to assess cellular viability and the other for qRT-PCR analysis.
46.2.2.2 Assessment of Cellular Viability—Cellular viability of the cultured control
and staurosporin-treated MDCK cells was assessed with a LIVE/DEAD® Viability/
Cytotoxicity Assay Kit (Invitrogen-Life Technologies, Carlsbad, CA) following the
manufacturer’s recommendation. Petri dishes containing the cells were examined by
epifluorescence microscopy (Axioplan, Carl Zeiss Meditech, Oberkochen, Germany).
Images were digitally captured (Spot 4.0 camera), and displayed with a graphics program
(Photoshop, Adobe, Mountain View, CA).
46.2.2.3 qRT-PCR Analysis—MDCK cells used for qRT-PCR analysis were harvested
by adding PBS and removing the cells from the Petri dishes with a plastic 16-cm cell
scraper. Total RNA from cell pellets was extracted, DNAse treated, and reverse-transcribed
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as previously described (Genini et al. 2010). qRT-PCR reactions containing 30 ng of mixed
cDNA at a ratio of 2:1 (5 hrs:10 hrs) also were performed as recently described (Genini et
al. 2010).

46.3 Results
We developed a profiling array containing 96 canine specific TaqMan probes to test the
expression of genes related to pro-apoptotic and anti-apoptotic processes. The selected genes
belong to 7 main categories that inform on signaling pathways and disease mechanisms, e.g.
1) pro-death, mitochondria-dependent; 2) pro-death, mitochondria-independent; 3)
autophagy; 4) pro-survival; 5) microglia/macrophage related; 6) expressed in retina [rods or
cones (ARR3, OPN1SW, OPN1MW, and RHO), Müller cells and astrocytes (GFAP and
VIM), bipolar cells (PKCA), and in the retinal pigment epithelium (BEST1)]; 7)
housekeeping genes (18S, ACTB, and GAPDH). Table 46.1 provides a summary of the 96
genes included in the array with their symbols, descriptions, categories, TaqMan assay
numbers (ABI), and location on the array.
To evaluate in detail and to confirm the nature of the 96 selected genes, we analyzed them
with the IPA program. As expected, the five most relevant IPA molecular and cellular
functions identified were cell death, cell-mediated immune response, cellular development,
function, and maintenance, as well as DNA replication, recombination, and repair (Table
46.2). Inflammatory disease, immunological disease, neurological disease, cancer, and
skeletal and muscular disorders were the five IPA biological functions related to “diseases
and disorders” with the highest number of genes (Table 46.2). Furthermore, relevant IPA
pathways included death receptor signaling, apoptosis signaling, TNFR1 signaling,
induction of apoptosis by HIV1, and tumoricidal function of hepatic natural killer cells
(Table 46.2).
The profiling array was validated, and the functionality of the TaqMan assays was tested,
with RNA extracted from control and staurosporin-treated MDCK cells. To examine the
highest number of genes possible, we mixed with a ratio of 2:1 the cDNAs of the
staurosporin-treated cells at 5 hrs (to detect early apoptotic genes) and 10 hrs (to detect late
apoptotic genes). The cDNAs from age-matched untreated cells at 5 and 10 hrs post addition
of fresh DMEM medium were processed similarly. While the untreated cells were mostly all
alive at 5 hrs (Fig. 46.1A) and 10 hrs (Fig. 46.1C), several staurosporin-treated cells were
dead at 5 hrs (Fig. 46.1B) and almost all at 10 hrs (Fig. 46.1D) of treatment.
The qRT-PCR results showed that retina-specific control genes did not amplify (BEST1,
OPN1LW, and OPN1SW), or had very high CT values between 35 and 38 (ARR3, GFAP,
and RHO) in both untreated and treated cells. Furthermore, the additional genes BNIP3L,
BID, CASP14, CD40, CD40LG, FADD, IL10, TNFA, TNFRSF9, TNFSF8, TNFRSF21, and
TYROBP did not amplify in MDCK cells. For the remaining genes, CT values ranged from
10 (18S) to 34 (FASLG, NTF3, NTF4, PRDX3, PTPRC, and TP73). The calculated mean CT
values of GAPDH and ACTB were used for normalization because they did not change
between treated and control samples, while 18S was excluded as it was unstable and highly
variable.
A total of 8 genes (BCL2L1, BCL2L11, CASP10, CCL2, DDIT3, HSP70, NGF, and TRAF2)
showed FC differences >3 in control vs. staurosporin-treated cells, while 4 (the retinal genes
ARR3, GFAP, and RHO, as well as IL6) showed opposite regulation. The expressions of
BNIP3, TNFA, and GFAP were also assessed with single assays done separately. The same
experimental conditions used for qRT-PCR on the profiling array were applied, with the
exception that the quantity of cDNA was augmented to 100 ng per gene and that other
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primers for BNIP3 (Genini et al. 2010) were used. The results demonstrated no changes in
expression of BNIP3, up-regulation of GFAP (raw CT values of 34 and 36, respectively) and
TNFA (raw CT values of 35 and 37, respectively) in staurosporin-treated vs. control cells.

46.4 Discussion and Conclusions
In the present study, we developed a qRT-PCR profiling array containing key genes that are
directly or indirectly involved in pro-apoptotic and pro-survival processes, autophagy, and/
or are related to microglia/macrophages. For all the selected genes, canine-specific TaqMan
assays are now inventoried and available for the research community. The array was
validated in canine origin MDCK cell cultures treated with staurosporin, and we identified a
number of genes that are important in pro-apoptotic and pro-survival processes, defined as
part of signaling pathways that activate apoptosis, attempt to block apoptosis, or attempt to
down or up-regulate protective cell functions. A precise and final classification of one gene
to one category was a very complex task, because several genes fit into different categories
depending on several factors (e.g. cell type, disease, age, interacting molecules) and because
this classification is a dynamic process that alters as more information becomes available.
Specific characterization of the selected genes with IPA confirmed their expected biological
functions and pathways, including cell death and cell mediated immune response, and
provided additional information to better evaluate and dissect the general pattern of the
genes on the profiling array.
A few genes, in particular those that are retinal-specific, could not be successfully amplified
in MDCK cells with 30 ng of cDNA. This might be due to absence or very low levels of
gene expression in MDCK cells, as shown with the single assay for TNFA that worked when
we used 100 ng of cDNA. Alternatively, this may have been caused by primers not
annealing to the sequence of interest. MDCK cells were used for this initial validation step
in order to save precious and limited canine retina samples; however additional validation
with RNA from retina will clarify the reasons for the failed amplification of certain genes.
This profiling array will be useful in future studies to identify genes, molecular mechanisms,
and signaling pathways associated with photoreceptor degeneration in XLPRA2 and also
additional canine models, e.g. rcd1, rcd2, XLPRA1, that carry mutations in other genes
known to cause retinal degeneration in humans. Inclusion of 3 housekeeping genes used for
normalization in the profiling array represents an advantage as it will enable selection of the
optimal combination for each different experiment that will be performed.
It is expected that such quantitative analyses of gene expression will be valuable in
identifying common, as well as disease-specific pro-death/pro-survival pathways that may
represent future novel therapeutic targets.
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Fig. 46.1.

LIVE/DEAD Viability/Cytotoxicity assay showing live (green) or dead (red) cells in control
(A, 5 hrs; C, 10 hrs) or staurosporin-treated (B, 5 hrs; D, 10 hrs) MDCK cultures. Note the
marked reduction in number of live cells after 10 hrs exposure to staurosporin.
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Table 46.1

List of the 96 genes included in the profiling array. Genes are reported with their symbols (in parenthesis the
alternative symbols), descriptions, categories, TaqMan assay numbers (ABI), and location on the array. Main
categories were: 1) pro-death, mitochondria-dependent; 2) pro-death, mitochondria-independent; 3)
autophagy; 4) pro-survival; 5) microglia/macrophage related; 6) positive control expressed in retina; 7)
housekeeping.
Gene symbol (alternative
symbol)

Gene description

Gene category

TaqMan® assay

Location on array

18S

eukaryotic 18S rRNA

7

Hs99999901_s1

A1

AIFM1 (AIF)

apoptosis-inducing factor, mitochondrionassociated 1

1

Cf02636601_m1

A2

SLC25A4 (ANT-1)

solute carrier family 25, member 4

1

Cf02730291_g1

A3

APAF1

apoptotic peptidase activating factor 1

1

Cf02695305_m1

A4

ATG3

autophagy related 3 homolog

3

Cf00684119_m1

A5

ATG5

autophagy related 5 homolog

3

Cf02637561_m1

A6

ATG7

autophagy related 7 homolog

3

Cf02656560_m1

A7

ATG12

autophagy related 12 homolog

3

Cf02641158_m1

A8

BAD (BBC2/BCL2L8)

BCL2-antagonist of cell death

1

Cf02627333_m1

A9

BAK1

BCL2-antagonist/killer 1

1

Cf02627218_m1

A10

BAX

BCL2-associated X protein

1

Cf02622186_g1

A11

BBC3 (PUMA)

BCL2 binding component 3

1

Cf02708330_m1

A12

BCL2

B-cell CLL/lymphoma 2

4

Cf02622425_m1

B1

BCL2L11 (BAM/BIM)

BCL2-like 11

1

Cf00708025_s1

B2

PABPN1 (BCL2L2)

poly(A) binding protein, nuclear 1

4

Cf02664611_m1

B3

BCL2L1 (BCL-XL)

BCL2-like 1

4

Cf02622161_m1

B4

BDNF

brain-derived neurotrophic factor

4, 5

Cf02622349_g1

B5

BECN1 (ATG6)

beclin 1

3

Cf02643377_m1

B6

BID

BH3 interacting domain death agonist

1

Cf03460096_m1

B7

GRP78 (BIP)

78 kDa glucose-regulated protein

4

Cf02631877_m1

B8

BNIP3 (NIP3)

BCL2/adenovirus E1B 19kDa interacting
protein 3

1

Cf02654885_m1

B9

BNIP3L (NIX)

BCL2/adenovirus E1B 19kDa-interacting
protein 3-like

1

Cf03460134_m1

B10

CASP10

caspase 10

1

Cf03460108_m1

B11

CASP14

caspase 14

2

Cf03460139_m1

B12

CASP2

caspase 2

1

Cf02624522_m1

C1

CASP3

caspase 3

1

Cf02622232_m1

C2

CASP4

caspase 4

1

Cf02623472_m1

C3

CASP6

caspase 6

1

Cf02652513_m1

C4

CASP7

caspase 7

1

Cf03460102_m1

C5

CASP8

caspase 8

1

Cf02627553_m1

C6

CASP9 (APAF3)

caspase 9

1

Cf02627331_m1

C7

SFRS2IP (CASP11)

splicing factor, arginine/serine-rich 2,
interacting protein

2

Cf02703447_m1

C8

CAPN1

calpain 1, (mu/I) large subunit

1

Cf02704115_m1

C9

Adv Exp Med Biol. Author manuscript; available in PMC 2014 March 19.

Genini et al.

Page 8

Gene symbol (alternative
symbol)

Gene description

Gene category

TaqMan® assay

Location on array

CAPN2

calpain 2, (mu/II) large subunit

1

Cf02645870_m1

C10

CAST

calpastatin

2

Cf02664849_m1

C11

CTSD

cathepsin D

3

Cf02625552_m1

C12

CTSS

cathepsin S

3

Cf02625930_m1

D1

CCL2

chemokine (C-C motif) ligand 2

4, 5

Cf02671955_g1

D2

CD40 (TNFRSF5)

TNF receptor superfamily member 5

2, 4, 5

Cf02626290_m1

D3

CD40LG (CD154/TNFSF5)

CD40 ligand

2, 4, 5

Cf02623314_m1

D4

PTPRC (CD45)

protein tyrosine phosphatase, receptor type
C

1, 5

Cf02653185_m1

D5

CNTF

ciliary neurotrophic factor

4, 5

Cf03460095_sH

D6

CREB1

cAMP responsive element binding protein 1

4

Cf02667607_m1

D7

CYCS

cytochrome c, somatic

1

Cf02640410_g1

D8

TYROBP (DAP12/KARAP)

TYRO protein tyrosine kinase binding
protein

5

Cf02642009_m1

D9

DIABLO (SMAC/SMAC3)

diablo homolog

1

Cf02665346_m1

D10

ENDOG

endonuclease G

1

Cf02703061_u1

D11

FADD (GIG3/MORT1)

FAS-associating death domain-containing
protein

1

Cf03460155_m1

D12

FAS (TNFRSF6/APO-1/CD95)

TNF receptor superfamily, member 6

1

Cf02651136_m1

E1

FASLG (TNFSF6/CD95L/CD178)

FAS ligand

1

Cf02625215_s1

E2

BFGF (FGF2)

basic fibroblast growth factor

4, 5

Cf03460065_g1

E3

DDIT3 (GADD153/CHOP10)

DNA-damage-inducible transcript 3

2

Cf02654858_m1

E4

GAPDH

glyceraldehyde-3-phosphate dehydrogenase

7

Hs02786624_g1

E5

GDNF

glial cell derived neurotrophic factor

4, 5

Cf02691052_s1

E6

HIF1A

hypoxia-inducible factor 1, alpha subunit

4

Cf02741632_m1

E7

HRK (DP5/HARAKIRI)

BCL2 interacting protein

1

Cf02702255_g1

E8

HSPB1 (HSP27)

heat shock 27kDa protein 1

4

Cf02628297_m1

E9

HSPD1 (HSP60)

heat shock 60kDa protein 1 (chaperonin)

1, 4

Cf02668830_gH

E10

HSP70 (HSPA1)

heat shock protein 70

4

Cf02622418_g1

E11

HSP86 (HSP90AA1)

heat shock protein HSP90-alpha

4

Cf03460183_s1

E12

IGF1R (CD221)

insulin-like growth factor 1 receptor

4

Cf02625178_m1

F1

IL6 (IFNB2)

interleukin 6

2, 5

Cf02624282_m1

F2

IL10

interleukin 10

4, 5

Cf02624265_m1

F3

MAP1LC3A (LC3)

microtubule-associated protein 1 light chain
3 alpha

3

Cf02630406_m1

F4

LYZ

lysozyme

3

Cf02642933_m1

F5

PRKCZ (PKC2)

protein kinase C, zeta

4

Cf02674616_m1

F6

PRDX3

peroxiredoxin 3

4

Cf03460191_sH

F7

NGF

nerve growth factor

4, 5

Cf02625041_s1

F8

NTF3

neurotrophin 3

4, 5

Cf02700489_s1

F9

NTF4

neurotrophin 4

4

Cf02705704_s1

F10

SOD1

superoxide dismutase 1, soluble

1, 4

Cf02624276_m1

F11

STAT1

signal transducer and activator of
transcription 1

1

Cf02662970_m1

F12
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Gene symbol (alternative
symbol)

Gene description

Gene category

TaqMan® assay

Location on array

STAT3

signal transducer and activator of
transcription 3

4, 5

Cf02666647_m1

G1

BIRC5 (IAP4)

baculoviral IAP repeat-containing 5
(survivin)

4

Cf02628995_m1

G2

TNFA

tumor necrosis factor alpha

1, 2, 5

Cf02628236_m1

G3

TNFRSF1A

tumor necrosis factor receptor superfamily,
member 1A

1, 2

Cf02622751_m1

G4

TNFRSF21 (DR6)

tumor necrosis factor receptor superfamily,
member 21

2

Cf03460083_s1

G5

TNFRSF25 (APO-3/DDR3)

tumor necrosis factor receptor superfamily,
member 25

1, 2

Cf02653814_g1

G6

TNFSF10 (APO-2L/TRAIL)

tumor necrosis factor (ligand) superfamily,
member 10

1, 2

Cf03460069_m1

G7

TNFRSF9 (4-1BB/CD137)

tumor necrosis factor receptor superfamily,
member 9

2

Cf03460132_m1

G8

TNFSF8 (CD153/CD30L)

tumor necrosis factor (ligand) superfamily,
member 8

2

Cf03460158_m1

G9

TP53

tumor protein p53

1

Cf02623148_m1

G10

TP73

tumor protein p73

1, 4

Cf02680478_mH

G11

TRADD

TNFRSF1A-associated via death domain

1, 2

Cf02661903_m1

G12

TRAF2 (TRAP)

TNF receptor-associated factor 2

2

Cf02662893_m1

H1

TRAF3

TNF receptor-associated factor 3

2

Cf02659700_m1

H2

XIAP (AP13/BIRC4)

X-linked inhibitor of apoptosis

4

Cf02625207_m1

H3

ACTB

actin, beta

7

Hs03023880_g1

H4

RHO

rhodopsin

6

Cf02625669_m1

H5

OPN1SW

opsin 1 (cone pigments), short-wavesensitive, blue opsin

6

Cf03460200_m1

H6

OPN1LW

opsin 1 (cone pigments), long-wavesensitive, red/green opsin

6

Cf02622926_m1

H7

ARR3 (CAR/ARRX)

retinal cone arrestin 3

6

Cf03460116_m1

H8

VIM

vimentin

6

Cf02668853_g1

H9

GFAP

glial fibrillary acidic protein

6

Cf02655695_m1

H10

PKCA (PRKCA)

protein kinase C, alpha

6

Cf02655322_m1

H11

BEST1 (VMD2)

bestrophin 1

6

Cf02697409_gH

H12
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Table 46.2

Five most significant IPA biological functions (“molecular and cellular functions” or “disease and disorders”)
and canonical pathways identified with the 96 genes included in the profiling array.
IPA biological functions
Molecular and cellular functions
•

Cell death

•

Cell-mediated immune response

•

Cellular development

•

Cellular function and maintenance

•

DNA replication, recombination, and repair

Diseases and disorders
•

Inflammatory disease

•

Immunological disease

•

Cancer

•

Neurological disease

•

Skeletal and muscular disorders

IPA canonical pathways
•

Death receptor signaling

•

Apoptosis signaling

•

Induction of apoptosis by HIV1

•

TNFR1 signaling

•

Tumoricidal function of hepatic natural killer cells
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